Evidence map›Paper›PMID 40421803›Full record

ArticleNucleic acids research2025

The role of multivalency in the association of the eight twenty-one protein 2 (ETO2) with the nucleosome remodeling and deacetylase (NuRD) complex.

Glory Dan-Dukor, Shengzhe Shang, Gage O Leighton, Christopher R Travis, Timothy D Schwochert, Parnika Agrawal, Oyindamola Ajasa, Torry Li, Marcey L Waters, Gordon D Ginder and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Glory Dan-DukorDepartment of Chemical Biology and Medicinal Chemistry, University of North Carolina, Chapel Hill, NC 27599, United States.
Shengzhe ShangMassey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, United States.
Gage O LeightonDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.
Christopher R TravisDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599, United States.ORCID 0000-0003-0673-6978
Timothy D SchwochertDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.
Parnika AgrawalDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.
Oyindamola AjasaDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.
Torry LiDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.
Marcey L WatersDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599, United States.
Gordon D GinderMassey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, United States.
David C WilliamsDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
The Role of the MBD2-NuRD Complex in Gamma-Globin Gene SilencingR01DK115563 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GINDER, GORDON D, WILLIAMS, DAVID COLLIN · 2018 to 2025
$6.3M
NIH Administrative Supplement to Purchase a LyophilizerR35GM145227 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARCEY L WATERS · 2022 to 2026
$2.2M
Origins of Ligand Binding and Selectivity in Methyllysine Reader and Writer ProteinsR01GM118499 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WATERS, MARCEY L · 2017 to 2022
$1.6M
Regulation of Globin Gene Expression In Erythroid Differentiation & DevelopmentR56DK029902 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GINDER, GORDON D · 2012 to 2012
$135k
National Institute of Diabetes, Digestive, and Kidney Diseases R01DK115563National Institute of Diabetes, Digestive, and Kidney Diseases R56DK29902NCI NIH HHS P30 CA016059NCI NIH HHS P30 CA016086NCI NIH HHS P30CA16086NIDDK NIH HHS R01 DK115563NIDDK NIH HHS R56 DK029902NIGMS NIH HHS R01 GM118499NIGMS NIH HHS R01GM118499NIGMS NIH HHS R35 GM145227NIGMS NIH HHS R35GM145227UNC Eshelman School of PharmacyUNC Lineberger Cancer Center P30CA016059UNC Lineberger Comprehensive Cancer CenterVCU Massey Cancer Center
6 · The paper itself

Abstract

Over the past 50 years, research has uncovered the co-regulatory proteins and complexes that silence the expression of the γ-globin gene in a developmental stage-specific manner. Recent research expanded the list of these regulatory factors by showing that the eight twenty-one protein 2 (ETO2) helps recruit the nucleosome remodeling and deacetylase (NuRD) complex to the globin locus. Furthermore, ETO2 regulates hematopoietic differentiation and is a potential therapeutic target for acute leukemia. In this work, we identify critical interactions between ETO2 and the GATA Zn finger domain containing the 2A (GATAD2A) component of NuRD. The ETO2 nervy homology region 4 (NHR4) domain interacts with multiple polyproline-leucine motifs within GATAD2A. We demonstrate that oligomerization of the ETO2 nervy homology region 3 (NHR3) enhances its affinity for peptides containing at least two polyproline-leucine motifs. Replacing the native motifs from GATAD2A with a higher-affinity sequence from known-binder N-CoR markedly enhances binding affinity, yielding a peptide that disrupts the interaction between ETO2 and target proteins. Enforced peptide expression elevates γ-globin expression levels and induces differentiation of HUDEP-2 and K562 cells. These findings provide insight into ETO2-mediated recruitment of co-regulatory proteins and yield a novel approach for ETO2 inhibition through multivalent binding of the NHR4 domain.

Indexed as

Mi-2 Nucleosome Remodeling and Deacetylase ComplexAmino Acid MotifsCell DifferentiationCo-Repressor ProteinsHumansK562 CellsNucleosomesProtein BindingCo-Repressor ProteinsMi-2 Nucleosome Remodeling and Deacetylase ComplexNucleosomes

Identifiers

PMID40421803
PMCPMC12107431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.